AzTrials
AzTrials

Mechanical Ventilation Weaning From Mechanical Ventilation Extubation Failure Critical IllnessDELTA-EXTNCT07634783

Delta Pocc During Spontaneous Breathing Trial to Predict Extubation Failure in Mechanically Ventilated Adults (DELTA-EXT)

An observational study of Mechanical Ventilation Weaning From Mechanical Ventilation Extubation Failure Critical Illness, run by Sanatorio Parque, Argentina at 1 site in Argentina.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This prospective observational single-center study will evaluate whether dynamic respiratory stress estimated by delta airway occlusion pressure deflection (Delta Pocc) during a standardized spontaneous breathing trial can predict extubation failure in mechanically ventilated adult intensive care unit patients. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Delta Pocc Measurement During Spontaneous Breathing Trial
How many people
120 participants
Where
1 siteArgentina
Study dates
Aug 2026to Aug 2027
How long will I take part?
2 Days
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adult intensive care unit patients receiving invasive mechanical ventilation for at least 24 hours who are considered clinically ready for a spontaneous breathing trial as part of routine weaning assessment.

Who may be able to join

  • Age 18 years or older
  • Invasive mechanical ventilation for at least 24 hours
  • Clinical indication for spontaneous breathing trial according to the treating clinical team
  • Hemodynamic and clinical stability
  • Technical feasibility for respiratory physiological measurements, including expiratory occlusion maneuver

Who cannot join

  • Significant hemodynamic instability
  • Severe uncontrolled hypoxemia
  • Major cardiac arrhythmias
  • Agitation or patient-ventilator asynchrony preventing reliable measurements
  • Significant air leak interfering with respiratory measurements
  • Technical inability to perform expiratory occlusion maneuver
  • Limitation of life-sustaining treatment
  • Incomplete primary outcome follow-up

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Gabriel A Musso, PT, MSc contact

+54 9 3413068143

udikcar@ugr.edu.ar

Maria C Gomez, PT, MSc contact

+54 9 3415462918

cgomez@ugr.edu.ar

Argentina1 site
  • Sanatorio Parque

    Rosario, Santa Fe Province, 2000

    Gabriel A Musso, PT, MSc, +54 9 3413068143, gmusso@ugr.edu.ar

    Maria C Gomez, PT, MSc, +5493415462918, cgomez@ugr.edu.ar

Other trials in Argentina

About this study

Official title: Prospective Observational Single-Center Physiological Study Evaluating Dynamic Stress Estimated by Delta Pocc During a Pressure Support Spontaneous Breathing Trial (PSV 8 cmH2O, PEEP 0 cmH2O) as a Predictor of Extubation Failure in Mechanically Ventilated Adult ICU Patients

This prospective observational single-center study will evaluate whether dynamic respiratory stress estimated by delta airway occlusion pressure deflection (Delta Pocc) during a standardized spontaneous breathing trial can predict extubation failure in mechanically ventilated adult intensive care unit patients.

Liberation from invasive mechanical ventilation is a critical step in ICU care. Although spontaneous breathing trials are routinely used to assess readiness for extubation, some patients may successfully complete the trial despite experiencing excessive respiratory effort and physiological stress, which may increase the risk of extubation failure.

Read more

This study will include adult ICU patients who have received invasive mechanical ventilation for at least 24 hours and are considered ready for a spontaneous breathing trial according to the treating clinical team. During the trial, respiratory, ventilatory, and hemodynamic variables will be recorded at predefined time points, including measurements of Delta Pocc as a non-invasive estimate of inspiratory effort and dynamic stress.

The primary outcome is extubation failure within 48 hours after extubation, defined as reintubation and/or the need for rescue non-invasive respiratory support due to post-extubation respiratory deterioration.

The study aims to determine whether this physiological measurement may improve risk stratification during weaning and complement conventional clinical decision-making.

Read the detailed description

Background

Liberation from invasive mechanical ventilation requires integration of clinical, hemodynamic, gas exchange, and physiological criteria. The spontaneous breathing trial (SBT) is a standard component of the weaning process and is commonly used to assess readiness for extubation. However, conventional clinical parameters may not fully capture the true respiratory workload experienced by the patient during the trial.

Some patients may tolerate a spontaneous breathing trial according to standard criteria while still developing excessive inspiratory effort and elevated dynamic respiratory stress, potentially predisposing them to post-extubation respiratory failure. Identifying these patients before extubation remains a major clinical challenge.

Delta airway occlusion pressure deflection (Delta Pocc), obtained during a brief expiratory occlusion maneuver, has emerged as a non-invasive physiological surrogate for inspiratory effort and dynamic transpulmonary stress. Incorporating this measurement into routine spontaneous breathing trial assessment may improve identification of patients at increased risk of extubation failure.

Objective

The primary objective of this study is to evaluate the predictive ability of Delta Pocc measured during a standardized spontaneous breathing trial to identify patients at risk of extubation failure within 48 hours.

Secondary objectives include:

To describe the temporal evolution of Delta Pocc and other respiratory physiological variables during the spontaneous breathing trial.

To compare respiratory effort and physiological measurements between patients with successful extubation and those with extubation failure.

To explore the discriminatory performance of Delta Pocc compared with conventional weaning variables.

To evaluate associations between Delta Pocc and clinically relevant outcomes including reintubation, rescue respiratory support, ICU length of stay, hospital length of stay, and mortality.

Study Design

This is a prospective, observational, single-center physiological study conducted in the adult intensive care unit of Sanatorio Parque.

The study does not modify standard clinical management. Participation will not delay extubation decisions or replace the clinical judgment of the treating team.

Study Population

Adult ICU patients receiving invasive mechanical ventilation for at least 24 hours who meet clinical criteria for a spontaneous breathing trial according to routine clinical practice will be eligible.

Inclusion Criteria Age 18 years or older Invasive mechanical ventilation for at least 24 hours Clinical indication for spontaneous breathing trial Hemodynamic and clinical stability Technical feasibility for physiological measurements Exclusion Criteria Significant hemodynamic instability Severe uncontrolled hypoxemia Major arrhythmias Agitation or patient-ventilator asynchrony preventing reliable measurements Significant air leak Technical inability to perform expiratory occlusion maneuver Limitation of life-sustaining treatment Procedures

Baseline respiratory, ventilatory, and hemodynamic variables will be recorded under current ventilatory settings.

A standardized spontaneous breathing trial will then be performed using:

Pressure support ventilation (PSV): 8 cmH2O Positive end-expiratory pressure (PEEP): 0 cmH2O

Measurements will be recorded at:

Baseline 15 minutes 30 minutes

Collected variables include:

Delta Pocc P0.1 Estimated inspiratory muscle pressure Negative inspiratory force Respiratory rate Rapid shallow breathing index Minute ventilation Peak airway pressure Mean airway pressure Oxygen saturation Heart rate Blood pressure Mean arterial pressure Fraction of inspired oxygen

Extubation decisions, preventive non-invasive respiratory support, rescue respiratory support, and reintubation will remain entirely at the discretion of the treating clinical team according to institutional practice.

Outcomes Primary Outcome

Extubation failure within 48 hours after extubation, defined as:

Reintubation, and/or Rescue non-invasive respiratory support due to respiratory deterioration after extubation Secondary Outcomes Spontaneous breathing trial success or failure Cause of spontaneous breathing trial failure Preventive non-invasive respiratory support Reintubation Rescue non-invasive respiratory support Duration of mechanical ventilation ICU length of stay Total hospital length of stay In-hospital mortality Statistical Considerations

The study is designed to evaluate the discriminative performance of Delta Pocc as a predictor of extubation failure.

Receiver operating characteristic (ROC) analysis will be used to assess predictive performance. Repeated physiological measurements will be analyzed using appropriate repeated-measures statistical methods. Multivariable logistic regression may be performed if the number of outcome events is sufficient.

A planned sample size of approximately 110 to 120 patients is expected to provide adequate event capture for exploratory predictive modeling.

Safety

This is a minimal-risk observational study. The only study-specific physiological maneuver is a brief expiratory occlusion measurement performed within standard ventilatory monitoring conditions.

No investigational drugs or devices are involved.

Being tested
Delta Pocc Measurement During Spontaneous Breathing Trial
Keywords
ΔPocc Spontaneous Breathing Trial Extubation Failure Weaning Respiratory Effort

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Delta Pocc Measurement During Spontaneous Breathing TrialDiagnostic test

    Delta airway occlusion pressure deflection will be measured during a standardized spontaneous breathing trial using pressure support ventilation of 8 cmH2O and PEEP of 0 cmH2O. Delta Pocc will be obtained through a brief expiratory occlusion maneuver and analyzed as a non-invasive physiological estimate of inspiratory effort and dynamic respiratory stress. The measurement will not replace clinical judgment or modify standard extubation decisions.

Study groups in NCT07634783
Study groupRoleWhat they receive
Mechanically Ventilated Adult ICU Patients Undergoing Spontaneous Breathing TrialNot described
Receives: Diagnostic Test: Delta Pocc Measurement During Spontaneous Breathing Trial

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of Participants With Extubation Failure Within 48 Hours

    Number of participants experiencing extubation failure, defined as reintubation and/or the need for rescue non-invasive respiratory support due to respiratory deterioration after extubation.

    Measured: Within 48 hours after extubation

Secondary outcomes (6)
  1. Change in Delta Pocc During the Spontaneous Breathing Trial

    Delta airway occlusion pressure deflection (Delta Pocc) measured at baseline, 15 minutes, and 30 minutes during the spontaneous breathing trial. The change from baseline and the highest value recorded during the trial will be analyzed.

    Measured: Baseline, 15 minutes, and 30 minutes during the spontaneous breathing trial

  2. P0.1 During the Spontaneous Breathing Trial

    Airway occlusion pressure measured 100 milliseconds after the onset of inspiration (P0.1) at baseline, 15 minutes, and 30 minutes during the spontaneous breathing trial.

    Measured: Baseline, 15 minutes, and 30 minutes during the spontaneous breathing trial

  3. Number of Participants Requiring Reintubation

    Number of participants requiring reintubation due to post-extubation respiratory failure.

    Measured: Within 48 hours after extubation

  4. Number of Participants Requiring Rescue Non-Invasive Respiratory Support

    Number of participants requiring rescue non-invasive ventilation (NIV) and/or high-flow nasal oxygen therapy (HFNO) because of respiratory deterioration following extubation.

    Measured: Within 48 hours after extubation

  5. Intensive Care Unit Length of Stay

    Total number of days spent in the intensive care unit from ICU admission until ICU discharge.

    Measured: Through ICU discharge, an average of 30 days

  6. Number of Participants Who Died During Hospitalization

    Number of participants who died during the index hospitalization.

    Measured: Through hospital discharge, an average of 60 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jun 2026
  2. Study startAug 2026 (estimated)
  3. Primary completionAug 2027 (estimated)
  4. Study completionAug 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
120 participants (estimated)
Target duration
2 Days
IDs, dates and publications
ClinicalTrials.gov ID
NCT07634783
Sponsor's protocol ID
SP-DELTAPOCC-EXTFAIL-2026
Other IDs
SP-DELTAPOCC-EXTFAIL-2026
Acronym
DELTA-EXT
Status last verified
Jun 2026
First submitted
27 May 2026
Last updated
25 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data are not planned to be shared because this is a single-center observational study and no formal institutional data-sharing infrastructure is currently in place. De-identified aggregate study results will be reported in scientific publications.

Publications

  • Thille AW, Gacouin A, Coudroy R, Ehrmann S, Quenot JP, Nay MA, Guitton C, Contou D, Labro G, Reignier J, Pradel G, Beduneau G, Dangers L, Saccheri C, Prat G, Lacave G, Sedillot N, Terzi N, La Combe B, Mira JP, Romen A, Azais MA, Rouze A, Devaquet J, Delbove A, Dres M, Bourenne J, Lautrette A, de Keizer J, Ragot S, Frat JP; REVA Research Network. Spontaneous-Breathing Trials with Pressure-Support Ventilation or a T-Piece. N Engl J Med. 2022 Nov 17;387(20):1843-1854. doi: 10.1056/NEJMoa2209041. Epub 2022 Oct 26.

    PubMed 36286317
  • van Oosten JP, Akoumianaki E, Jonkman AH. Monitoring respiratory muscles effort during mechanical ventilation. Curr Opin Crit Care. 2025 Feb 1;31(1):12-20. doi: 10.1097/MCC.0000000000001229. Epub 2024 Nov 14.

    PubMed 39560150
  • Bertoni M, Telias I, Urner M, Long M, Del Sorbo L, Fan E, Sinderby C, Beck J, Liu L, Qiu H, Wong J, Slutsky AS, Ferguson ND, Brochard LJ, Goligher EC. A novel non-invasive method to detect excessively high respiratory effort and dynamic transpulmonary driving pressure during mechanical ventilation. Crit Care. 2019 Nov 6;23(1):346. doi: 10.1186/s13054-019-2617-0.

    PubMed 31694692

Questions about this trial

What is this clinical trial studying?

An observational study of Mechanical Ventilation Weaning From Mechanical Ventilation Extubation Failure Critical Illness, run by Sanatorio Parque, Argentina at 1 site in Argentina.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 25 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Argentina. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Gabriel A Musso, PT, MSc (+54 9 3413068143, udikcar@ugr.edu.ar), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of Participants With Extubation Failure Within 48 Hours (time frame: Within 48 hours after extubation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07634783, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in